Towards 3% R&D – Boosting industry and research collaboration, by Dr Tony Peacock

With business and direct government spending on R&D falling, and only university research rising, our editorial series – Towards 3% R&D – Turbocharging Australia’s Innovation Effort – turns to collaboration between industry and public sector researchers. By Dr Tony Peacock. If Australia is to turbocharge our R&D to reach 3% of GDP, businesses will have…

Starpharma to establish UK joint venture

Pharmaceutical company Starpharma is to establish a new UK based company called Petalion Therapeutics Limited in joint venture with life sciences investment firm Medicxi,. Petalion will initially focus on developing novel targeted dendrimer-drug conjugate therapies in oncology, utilising Starpharma’s proprietary DEP dendrimer platform technology. Medicxi will fund Petalion with an initial investment of up to…